What Clinical Research Shows Clinical trials on GLP-1 medications have shown significant average weight loss when patients reached and maintained target doses while also following reduced-calorie diets and increasing physical activity
Our L-carnitine facility in Nansha, China where we also produce Carnifeed and Carniking upholds the highest standards in production and manufacturing, while prioritizing the safety of people and the environment
Rodriguez, conducted a cohort study involving 125,474 patients who started GLP-1 medications, including Victoza (liraglutide), Ozempic and Wegovy, and Mounjaro and Zepbound between January 1, 2018 and December 31, 2023
Female hair loss (androgenetic alopecia in women) involves the same follicle miniaturization mechanisms that GHK-Cu addresses follicle cell stimulation, anagen extension, and anti-inflammatory action